Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2636379312;79313;79314 chr2:178567045;178567044;178567043chr2:179431772;179431771;179431770
N2AB2472274389;74390;74391 chr2:178567045;178567044;178567043chr2:179431772;179431771;179431770
N2A2379571608;71609;71610 chr2:178567045;178567044;178567043chr2:179431772;179431771;179431770
N2B1729852117;52118;52119 chr2:178567045;178567044;178567043chr2:179431772;179431771;179431770
Novex-11742352492;52493;52494 chr2:178567045;178567044;178567043chr2:179431772;179431771;179431770
Novex-21749052693;52694;52695 chr2:178567045;178567044;178567043chr2:179431772;179431771;179431770
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: A
  • RefSeq wild type transcript codon: GCT
  • RefSeq wild type template codon: CGA
  • Domain: Fn3-79
  • Domain position: 78
  • Structural Position: 110
  • Q(SASA): 0.0941
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
A/T None None 1.0 D 0.781 0.706 0.57631073843 gnomAD-4.0.0 1.20033E-06 None None None None N None 0 0 None 0 0 None 0 0 1.31251E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
A/C 0.9367 likely_pathogenic 0.9143 pathogenic -1.687 Destabilizing 1.0 D 0.791 deleterious None None None None N
A/D 0.9974 likely_pathogenic 0.9977 pathogenic -2.579 Highly Destabilizing 1.0 D 0.871 deleterious D 0.573219226 None None N
A/E 0.9972 likely_pathogenic 0.9976 pathogenic -2.359 Highly Destabilizing 1.0 D 0.865 deleterious None None None None N
A/F 0.9961 likely_pathogenic 0.9957 pathogenic -0.52 Destabilizing 1.0 D 0.911 deleterious None None None None N
A/G 0.1782 likely_benign 0.1689 benign -2.122 Highly Destabilizing 1.0 D 0.613 neutral N 0.500851431 None None N
A/H 0.9984 likely_pathogenic 0.9986 pathogenic -1.989 Destabilizing 1.0 D 0.886 deleterious None None None None N
A/I 0.9946 likely_pathogenic 0.994 pathogenic -0.598 Destabilizing 1.0 D 0.867 deleterious None None None None N
A/K 0.9994 likely_pathogenic 0.9994 pathogenic -1.366 Destabilizing 1.0 D 0.863 deleterious None None None None N
A/L 0.9677 likely_pathogenic 0.9643 pathogenic -0.598 Destabilizing 1.0 D 0.793 deleterious None None None None N
A/M 0.9857 likely_pathogenic 0.9844 pathogenic -1.125 Destabilizing 1.0 D 0.867 deleterious None None None None N
A/N 0.9922 likely_pathogenic 0.9927 pathogenic -1.8 Destabilizing 1.0 D 0.9 deleterious None None None None N
A/P 0.5943 likely_pathogenic 0.6171 pathogenic -0.946 Destabilizing 1.0 D 0.873 deleterious N 0.518577293 None None N
A/Q 0.9952 likely_pathogenic 0.9956 pathogenic -1.487 Destabilizing 1.0 D 0.881 deleterious None None None None N
A/R 0.9973 likely_pathogenic 0.9975 pathogenic -1.487 Destabilizing 1.0 D 0.869 deleterious None None None None N
A/S 0.4716 ambiguous 0.5339 ambiguous -2.14 Highly Destabilizing 1.0 D 0.597 neutral N 0.514459008 None None N
A/T 0.9303 likely_pathogenic 0.9403 pathogenic -1.824 Destabilizing 1.0 D 0.781 deleterious D 0.557807088 None None N
A/V 0.9579 likely_pathogenic 0.9574 pathogenic -0.946 Destabilizing 1.0 D 0.7 prob.neutral D 0.552833565 None None N
A/W 0.9995 likely_pathogenic 0.9995 pathogenic -1.136 Destabilizing 1.0 D 0.859 deleterious None None None None N
A/Y 0.9981 likely_pathogenic 0.9979 pathogenic -0.917 Destabilizing 1.0 D 0.91 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.